Deutsche Bank Ag\ Aslan Pharmaceuticals LTD Transaction History

Deutsche Bank Ag\

  • $240 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$0.96 - $2.19 $1,137 - $2,595
-1,185 Closed
0 $0
Q1 2020

May 14, 2020
SELL
$0.93 - $2.8 $898 - $2,704
-966 Reduced 44.91%
1,185 $1,000
Q4 2019

Feb 14, 2020
SELL
$0.37 - $5.2 $7 - $104
-20 Reduced 0.92%
2,151 $4,000
Q3 2019

Nov 14, 2019
BUY
$1.51 - $3.85 $3,278 - $8,358
2,171 New
2,171 $3,000

Others Institutions Holding ASLN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ASLAN Pharmaceuticals Ltd

ASLN Quotes by TradingView
  • Ticker ASLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,744,704
  • Market Cap $41.8M
  • Description
  • ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...
More about ASLN
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email